SCHEMBL5273233

SCHEMBL5273233

Cc1c(C(=O)O)[nH]c2ccccc2c1=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.56
KDM4E B2RXH2 5/20 0.56
HPGD P15428 4/20 0.56
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
HSD17B10 Q99714 3/20 0.53
CAPN1 P07384 4/20 0.52
GAA P10253 2/20 0.52
HTT P42858 2/20 0.52
LMNA P02545 1/20 0.52
GLA P06280 1/20 0.52
ATM Q13315 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
POLB P06746 1/20 0.51
PBRM1 Q86U86 1/20 0.51
FOLH1 Q04609 1/20 0.50
MAPT P10636 2/20 0.49
USP2 O75604 1/20 0.49
GFER P55789 1/20 0.49
DAO P14920 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30000925 1.00 ALDH1A1 (0.56) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL2399274 0.89 ALDH1A1 (0.63) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL29897041 0.89 ALDH1A1 (0.63) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL30393982 0.81 KDM4E (0.57) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL756338 0.81 KDM4E (0.57) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL27469947 0.80 MEN1 (0.60) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL4463471 0.80 KDM4E (0.61) ALDH1A1KDM4EHPGDHSD17B10GAA
SCHEMBL30002774 0.80 KDM4E (0.61) ALDH1A1KDM4EHPGDHSD17B10GAA
SCHEMBL8682628 0.79 KDM4E (0.56) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL5270788 0.78 RAB9A (0.57) ALDH1A1KDM4EKMT2ACAPN1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7183412-B2 Ester or amide derivatives ASTELLAS PHARMA INC. (JP) 2007-02-27 US disclosed
CN-1735599-A 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands BOEHRINGER INGELHEIM PHARMA (US) 2006-02-15 CN disclosed
CN-1212317-C Novel ester or amide derivatives YAMANOUCHI PHARMA CO LTD (JP) 2005-07-27 CN disclosed
US-20050090497-A1 Novel ester or amide derivatives YAMANOUCHI PHARMACEUTICAL CO., LTD. 2005-04-28 US disclosed
US-6822098-B2 CARBOCYCLIC CARBO, OXO AMINES SUCH AS N-HEPTYL-3-METHYL-4-OXO -1,4-DIHYDROQUINOLINE-2-CARBOXAMIDE, USED FOR PROPHYLAXIS OF GASTROINTERSTINAL DISORDERS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-23 US disclosed
US-20040019214-A1 Novel ester or amide derivatives ASTELLAS PHARMA INC. (JP) 2004-01-29 US disclosed
CN-1449384-A Novel ester or amide derivatives YAMANOUCHI PHARMA CO LTD (JP) 2003-10-15 CN disclosed
EP-1314726-A1 NOVEL ESTER OR AMIDE DERIVATIVES YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2003-05-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040019214-A1 Novel ester or amide derivatives CYP3A7, UGT2B7, NAT1 ALDH1A1 122/4885KDM4E 1866/4885HPGD 1330/4885
US-20050090497-A1 Novel ester or amide derivatives CYP3A7, CYP7A1, UGT2B7 ALDH1A1 117/4885KDM4E 2052/4885HPGD 1424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.